Detection of antinuclear antibodies: recommendations from EFLM, EASI and ICAP
- PMID: 36989417
- DOI: 10.1515/cclm-2023-0209
Detection of antinuclear antibodies: recommendations from EFLM, EASI and ICAP
Abstract
Objectives: Antinuclear antibodies (ANA) are important for the diagnosis of various autoimmune diseases. ANA are usually detected by indirect immunofluorescence assay (IFA) using HEp-2 cells (HEp-2 IFA). There are many variables influencing HEp-2 IFA results, such as subjective visual reading, serum screening dilution, substrate manufacturing, microscope components and conjugate. Newer developments on ANA testing that offer novel features adopted by some clinical laboratories include automated computer-assisted diagnosis (CAD) systems and solid phase assays (SPA).
Methods: A group of experts reviewed current literature and established recommendations on methodological aspects of ANA testing. This process was supported by a two round Delphi exercise. International expert groups that participated in this initiative included (i) the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group "Autoimmunity Testing"; (ii) the European Autoimmune Standardization Initiative (EASI); and (iii) the International Consensus on ANA Patterns (ICAP).
Results: In total, 35 recommendations/statements related to (i) ANA testing and reporting by HEp-2 IFA; (ii) HEp-2 IFA methodological aspects including substrate/conjugate selection and the application of CAD systems; (iii) quality assurance; (iv) HEp-2 IFA validation/verification approaches and (v) SPA were formulated. Globally, 95% of all submitted scores in the final Delphi round were above 6 (moderately agree, agree or strongly agree) and 85% above 7 (agree and strongly agree), indicating strong international support for the proposed recommendations.
Conclusions: These recommendations are an important step to achieve high quality ANA testing.
Keywords: HEp-2 indirect immunofluorescence; antinuclear antibodies; recommendations.
© 2023 Walter de Gruyter GmbH, Berlin/Boston.
References
-
- Bossuyt, X, De Langhe, E, Borghi, MO, Meroni, PL. Understanding and interpreting antinuclear antibody tests in systemic rheumatic diseases. Nat Rev Rheumatol 2020;16:715–26. https://doi.org/10.1038/s41584-020-00522-w . - DOI
-
- Martini, A, Ravelli, A, Avcin, T, Beresford, MW, Burgos-Vargas, R, Cuttica, R, et al.. Toward new classification criteria for juvenile idiopathic arthritis: first steps, pediatric Rheumatology international trials organization international consensus. J Rheumatol 2019;46:190–7. https://doi.org/10.3899/jrheum.180168 . - DOI
-
- Vergani, D, Alvarez, F, Bianchi, FB, Cancado, EL, Mackay, IR, Manns, MP, et al.. Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group. J Hepatol 2004;41:677–83. https://doi.org/10.1016/j.jhep.2004.08.002 . - DOI
-
- EASL, Beuers, U, Corpechot, C, Invernizzi, P, Jones, D, Marzioni, M, et al.. EASL clinical practice guidelines: the diagnosis and management of patients with primary biliary cholangitis. J Hepatol 2017;67:145–72. https://doi.org/10.1016/j.jhep.2017.03.022 . - DOI
-
- Francescantonio, PL, Cruvinel Wde, M, Dellavance, A, Andrade, LE, Taliberti, BH, von Muhlen, CA, et al.. IV Brazilian guidelines for autoantibodies on HEp-2 cells. Rev Bras Reumatol 2014;54:44–50. https://doi.org/10.1016/j.rbre.2014.02.006 . - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous